Chona Chua

Senior Manager at Amgen, Inc.

Chona Chua

Chona Chua

Senior Manager at Amgen, Inc.

Overview
RelSci Relationships

1733

Contact Data
Trying to get in touch with Chona Chua? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Chona Chua likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior Vice President & Chief Compliance Officer at Amgen, Inc.

Relationship likelihood: Weak

Director, Information Systems at Amgen, Inc.

Relationship likelihood: Weak

Senior Vice President, General Manager, US General Medicine at Amgen, Inc.

Relationship likelihood: Weak

Head, Global Media Relations at Amgen, Inc.

Relationship likelihood: Weak

Director, State Government Affairs at Amgen, Inc.

Relationship likelihood: Weak

Medical Director at Amgen, Inc.

Relationship likelihood: Weak

Head, Global Digital Engagement & Data Sciences-Amgen Digital Health at Amgen, Inc.

Relationship likelihood: Weak

Senior Vice President of Translational Medicine at Adaptive Biotechnologies Corp.

Relationship likelihood: Weak

Clinical Operations Manager at Amgen, Inc.

Relationship likelihood: Weak

Scientific Director at Amgen, Inc.

Relationship likelihood: Weak

Paths to Chona Chua
Potential Connections via
Relationship Science
You
Chona Chua
Senior Manager at Amgen, Inc.
Career History
Senior Manager
Tenure Unconfirmed

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Other Affiliations

Chona Chua is affiliated with Amgen, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Chona Chua. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Chona Chua's profile does not indicate a business or promotional relationship of any kind between RelSci and Chona Chua.